Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06421142 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

FAPI and FDG PET/MRI in Diagnosis and Therapy Prediction of Bladder Cancer

StatusRecruiting
PhaseNot applicable
Started2024-08-02
View on ClinicalTrials.gov ↗

Amendment history

2026-05-28
Study Status, Contacts/Locations v5
Trial status changed: Active, Not Recruiting → Recruiting
Primary completion pushed: 2026-10-01 → 2028-08-01
Completion pushed: 2026-12-31 → 2029-06-01
Start date2025-11-01→2024-08-02
Study sitesdetails revised at 1 of 1 site
2026-04-08
Recruiting→Active, Not Recruiting Study Status, Oversight, Contacts/Locations v4
Trial statusRecruiting→Active, Not Recruiting
Start date2024-09-01→2025-11-01
Study sitesdetails revised at 1 of 1 site
2025-09-09
Study Status, Oversight v3
Primary completion date2025-06-01→2026-10-01
Completion date2025-06-01→2026-12-31
Start date2024-07-01→2024-09-01
2024-09-25
Not Yet Recruiting→Recruiting Study Status, Contacts/Locations v2
Trial statusNot Yet Recruiting→Recruiting
Study sites0→1
2024-06-19
Study Status v1
Start date2024-06-01→2024-07-01
2024-05-15
Original filing
The aim of this trial is to investigate the value of FAPI PET/MRI, FDG PET/MRI and MRI in diagnosing MIBC and predicting the efficacy of neoadjuvant therapy for MIBC patients, so as to guide the clinic to adjust the treatment plan in time and benefit MIBC patients.
Trial Details
NCT Number NCT06421142
Lead Sponsor First Affiliated Hospital of Fujian Medical University
Conditions Urinary Bladder Neoplasms
Enrollment 80 participants
Start Date 2024-08-02
Primary Completion 2028-08-01 (estimated)
Study Completion 2029-06-01 (estimated)
Updated on ClinicalTrials.gov 2026-06-01